The Tara Health Foundation sought an annual report on whether Pfizer’s political, lobbying and electioneering expenses are consistent with its goal to “end discrimination against women, ensure equal opportunities for leadership and access to reproductive health,” among other environmental, social and governance objectives. The proposal received 13.7% of investor votes, according to preliminary results announced at Pfizer’s annual meeting on Thursday.
Pfizer’s political spending appears to conflict with its stated interests and values, Tara ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.